Stocks in play: Microbix Biosystems Inc.
Is presenting results of its use of Microbix Quality Assessment Products for accreditation of clinical labs for conducting molecular tests for antimicrobial-resistant strains of M. genitalium, a common sexually-transmitted infection. Microbix Biosystems Inc. shares T.MBX are trading unchanged at $0.34.
Read:
Multi-Billion-Dollar Offers Not Enough to Get Lithium Asset Owners to Bite for Mining Giants
The Future of Corporate Innovation Explores the Expanding Role of Artificial Intelligence
Navigating the Surge in Aquaculture: Opportunities & Challenges
Tech Sector’s AI Advancements Boosting Economic Momentum, Reshaping 90% of US Jobs
More Safe and Secure Lithium Being Sought by the World’s Auto Giants in EV Production